# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATIONDECISION SUMMARYINSTRUMENT ONLY TEMPLATE

A. 510(k) Number: k093789 B. Purpose for Submission: Symcare is seeking OTC clearance for the InTouch (formerly Symcare) Diabetes Management Program cleared for prescription use under k083263 using the Polymap Wireless Polytel GMA glucose meter data transmission accessory originally cleared under k070559 for prescription use and more currently cleared for OTC use under k091296. The Symcare Diabetes Management Program has been renamed InTouch Diabetes Management Program. C. Manufacturer and Instrument Name: Symcare Personalized Health Solutions, Inc InTouch Diabetes D. Type of Test or Tests performed: Glucose data transmission E. System Descriptions:   
1. Device Description: The InTouch Diabetes Management Program (DMP) is an online tool that helps patients to manage their diabetes and communicate their blood glucose readings to their invited healthcare professionals, who they partner with in managing their diabetes. A validated blood glucose meter connected via a Bluetooth accessory, “the Polymap Wireless Polytel Glucose Meter Accessory (GMA)” (k091296), to a validated cellular phone, is used to transmit glucose readings from the glucose meter to the DMP online system, which is accessible by the healthcare provider, as well as the patient.   
2. Principles of Operation: Not applicable   
3. Modes of Operation: Not applicable

4. Specimen Identification: Not applicable

5. Specimen Sampling and Handling:

Not applicable

6. Calibration: Not applicable

7. Quality Control: External quality control is not applicable for data transmission.

8. Software:

FDA has reviewed the applicant’s Hazard Analysis and software Documentation: Yes __X___ or No

Subject of k083263 review

# F. Regulatory Information:

1. Regulation Section: 21CFR §862.1345 -Glucose test system. 21CFR §862.2100 - Calculator/Data Processing Module for Clinical Use.

2. Classification: Class 2, I respectively

3. Product Code: NBW, JQP

4. Panel: Chemistry (75)

# G. Intended Use:

1. Indication(s) for Use:

InTouch Diabetes Management Program is intended for use in home settings to aid people with diabetes and healthcare professionals in the review, analysis and evaluation of historical blood glucose test results to support effective diabetes management. It is intended for use as an accessory to blood glucose meters with data management capabilities. This system is intended for use by people 18 years of age and older. InTouch Diabetes Management Program is not intended to provide treatment decisions or to be used as a substitute for professional healthcare judgment. All patient medical diagnoses and treatment are to be performed under the supervision and oversight of an appropriate healthcare professional.

2. Special Condition for use Statement(s): None

# H. Substantial Equivalence Information:

1. Predicate device name(s)and 510(k) numbers: MCT Diabetes™ V2.0 k073699

2. Comparison with Predicate Device:

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>InTouchTM•diabetesVersion 2.1</td><td rowspan=1 colspan=1>OriginalSymCare DMP 2.03K083263</td><td rowspan=1 colspan=1>MCT DiabetesTMV2.0K073699</td></tr><tr><td rowspan=1 colspan=1>IntendedUsers</td><td rowspan=1 colspan=1>Home users,healthcare providers(including SymCarehealthcareprofessionals), andinsurance payers</td><td rowspan=1 colspan=1>Home users byprescription,healthcare providers(including SymCarehealthcareprofessionals), andinsurance payers</td><td rowspan=1 colspan=1>Home use orclinical assistdiabetics, families,and professionals inmanagement ofblood glucosesupport diabetesmanagement</td></tr><tr><td rowspan=1 colspan=1>Prescriptionor OT Use</td><td rowspan=1 colspan=1>OTC &amp; Prescription</td><td rowspan=1 colspan=1>Prescription</td><td rowspan=1 colspan=1>OTC</td></tr><tr><td rowspan=1 colspan=1>SoftwareUse</td><td rowspan=1 colspan=1>Single (individual) ormultiple user(clinical) settings</td><td rowspan=1 colspan=1>Single (individual) ormultiple user(clinical) settings</td><td rowspan=1 colspan=1>Single (individual)or multiple user(clinical) settings</td></tr><tr><td rowspan=1 colspan=1>Installationof Program</td><td rowspan=1 colspan=1>Internet link</td><td rowspan=1 colspan=1>Internet link</td><td rowspan=1 colspan=1>Internet link</td></tr><tr><td rowspan=1 colspan=1>Communication Method</td><td rowspan=1 colspan=1>Cellular phone</td><td rowspan=1 colspan=1>Cellular phone</td><td rowspan=1 colspan=1>Cellular phone</td></tr><tr><td rowspan=1 colspan=1>Connectivity</td><td rowspan=1 colspan=1>Bluetooth</td><td rowspan=1 colspan=1>Bluetooth</td><td rowspan=1 colspan=1>Bluetooth</td></tr><tr><td rowspan=1 colspan=1>Display</td><td rowspan=1 colspan=1>Cellular telephoneand monitorsconnected to a centralserver</td><td rowspan=1 colspan=1>Cellular telephoneand monitorsconnected to a centralserver</td><td rowspan=1 colspan=1>Cellular telephoneand monitorsconnected to acentral server</td></tr><tr><td rowspan=1 colspan=1>Type ofdevices thatcan beinterfaced</td><td rowspan=1 colspan=1>LifeScan OneTouch®Ultra® and Ultra® I1MetersAs additionalsoftware protocolsare obtained anddevices are validated,capabilities will bebroadened to includeother meters</td><td rowspan=1 colspan=1>LifeScan OneTouch®Ultra® and Ultra® I1MetersAs additionalsoftware protocolsare obtained anddevices are validated,capabilities will bebroadened to includeother meters</td><td rowspan=1 colspan=1>Wide range ofsupported metersare listed onwebsite;As additionalsoftware protocolsare obtained anddevices are valida-ted, capabilitieswill be broadenedto include othermeters</td></tr></table>

I. Standard/Guidance Document Referenced (if applicable): None were referenced.

# J. Performance Characteristics:

# 1. Analytical Performance:

a. Accuracy: Not applicable   
b. Precision/Reproducibility: Not applicable   
c. Linearity: Not applicable   
d. Carryover: Not applicable   
e. Interfering Substances: Not applicable

2. Other Supportive Instrument Performance Data Not Covered Above:

Human Factors studies for the entire system with U.S. labeling, using lay people were performed to support the OTC claim.

# K. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# L. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.